日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma.

在高危神经母细胞瘤的临床前模型中,精氨酸耗竭可增强标准治疗化疗免疫疗法的疗效

Hanssen Kimberley M, Murray Jayne, Pandher Ruby, Alfred Stephanie, Gamble Laura D, Brand Jennifer, Mosmann Erin, Kusuma Frances K, Mak Crystal, Kearns Adam, Kamili Alvin, Atkinson Caroline, Minchaca Alexis Z, Bertoldo Jean, Ziegler David S, Mussai Francis, Cheng Paul N M, Norris Murray D, Fletcher Jamie I, Haber Michelle

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma

在多药联合化疗中加入JNK非依赖性药物可提高复发性高危神经母细胞瘤的疗效。

Han, Jeremy Z R; Phimmachanh, Monica; Hastings, Jordan F; Leong, King Ho; Ng, Boaz H; Ni, Jenny; Fontaine-Titley, Angela; Cadell, Antonia L; O'Donnell, Yolande Ei; Clearwater, Misaki; Kamili, Alvin; Haber, Michelle; Norris, Murray; Timpson, Paul; Trahair, Toby N; Fletcher, Jamie I; Fey, Dirk; Kolch, Walter; Latham, Sharissa L; Croucher, David R

The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response

细胞可渗透的铁螯合剂M606通过E2F3介导的反应抑制MYCN驱动的神经母细胞瘤。

Pandher, Ruby; Xue, Chengyuan; Gamble, Laura D; Milazzo, Giorgio; Di Giacomo, Simone; Murray, Jayne; Cheung, Leanna; Ferrucci, Francesca; Palombo, Marta; Purgato, Stefania; Burkhart, Catherine A; Fedtsova, Natalia; Gleiberman, Anatoli S; Purmal, Andrei A; Korotchkina, Lioubov; Nikiforov, Mikhail A; Makarov, Sergei S; Telfer, Thomas J; Codd, Rachel; Marshall, Glenn M; Scott, David A; Osterman, Andrei L; Gudkov, Andrei V; Perini, Giovanni; Haber, Michelle; Norris, Murray D

The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma.

多胺转运蛋白 ATP13A3 介导二氟甲基鸟氨酸诱导的神经母细胞瘤多胺摄取

Azfar Mujahid, Gao Weiman, Van den Haute Chris, Xiao Lin, Karsa Mawar, Pandher Ruby, Karsa Ayu, Spurling Dayna, Ronca Emma, Bongers Angelika, Guo Xinyi, Mayoh Chelsea, Fayt Youri, Schoofs Arthur, Burns Mark R, Verhelst Steven H L, Norris Murray D, Haber Michelle, Vangheluwe Peter, Somers Klaartje

Bridging the Gap: Embedding Psychosocial Oncology Research into Comprehensive Cancer Care for Children and Young People

弥合差距:将心理社会肿瘤学研究融入儿童和青少年综合癌症护理

Sansom-Daly, Ursula Margaret; McLoone, Jordana Kathleen; Fardell, Joanna Elizabeth; Evans, Holly Elaine; McGill, Brittany Claire; Robertson, Eden Grace; Signorelli, Christina; Ellis, Sarah; Ha, Lauren; Hetherington, Kate; Houweling, Rachel Elizabeth; Nevin, Suzanne Mary; Schilstra, Clarissa Evelyn; Mitchell, Richard; Haber, Michelle; Cohn, Richard Jules; Wakefield, Claire Elizabeth

Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.

利用斑马鱼模拟高危儿童癌症,为精准治疗提供信息

Azzam Nadine, Fletcher Jamie I, Melong Nicole, Lau Loretta M S, Dolman Emmy M, Mao Jie, Tax Gabor, Cadiz Roxanne, Tuzi Lissandra, Kamili Alvin, Dumevska Biljana, Xie Jinhan, Chan Jennifer A, Senger Donna L, Grover Stephanie A, Malkin David, Haber Michelle, Berman Jason N

Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists' Perspectives

儿童癌症精准医疗试验中的数据共享、活检和患者隐私:一项融合家长、肿瘤科医生和科学家观点的混合方法研究

Lei, Yvanna; Hetherington, Kate; Daly, Rebecca; Rensen, Niki; McGill, Brittany C; Ziegler, David S; Lau, Loretta M S; Tyrrell, Vanessa; Karpelowsky, Jonathan; Cowley, Mark J; Tucker, Katherine M; Haber, Michelle; Barahona, Paulette; Wakefield, Claire E

The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

PLK4 抑制剂 RP-1664 通过双重敏感性机制在神经母细胞瘤模型中表现出强大的单药疗效

Maris John, Soria-Bretones Isabel, Casás-Selves Matias, Samanta Minu, Groff David, Murray Jayne, Fletcher Jamie, Farrel Alvin, Pastor Steven, Patel Khushbu, Goodfellow Elliot Goodfellow, Li Li, Caron Cathy, Shiwram Ariya, Kim Hyeyeon, Henry Danielle, Laterreur Nancy, Bowlan Julian, Krytska Kateryna, Neuhauser Steven, Stearns Timothy, Schubert Jeffrey, Wu Jinhua, Surrey Lea, Álvarez-Quilón Alejandro, Vallée Frédéric, Nejad Parham, Schonhoft Joseph, Li Joanna, Veloso Artur, Young Jordan, Hyer Marc, Morris Stephen, Mossé Yael P, Marshall Gary, Haber Michelle, Zimmermann Michal

Precision-guided treatment in high-risk pediatric cancers

高危儿童癌症的精准指导治疗

Lau, Loretta M S; Khuong-Quang, Dong-Anh; Mayoh, Chelsea; Wong, Marie; Barahona, Paulette; Ajuyah, Pamela; Senapati, Akanksha; Nagabushan, Sumanth; Sherstyuk, Alexandra; Altekoester, Ann-Kristin; Fuentes-Bolanos, Noemi A; Yeung, Veronica; Sullivan, Ashleigh; Omer, Natacha; Diamond, Yonatan; Jessop, Sophie; Battaglia, Lauren; Zhukova, Nataliya; Cui, Louise; Lin, Angela; Gifford, Andrew J; Fleuren, Emmy D G; Dalla-Pozza, Luciano; Moore, Andrew S; Khaw, Seong-Lin; Eisenstat, David D; Gottardo, Nicholas G; Wood, Paul J; Tapp, Heather; Alvaro, Frank; McCowage, Geoffrey; Nicholls, Wayne; Hansford, Jordan R; Manoharan, Neevika; Kotecha, Rishi S; Mateos, Marion K; Lock, Richard B; Tyrrell, Vanessa; Haber, Michelle; Trahair, Toby N; Cowley, Mark J; Ekert, Paul G; Marshall, Glenn M; Ziegler, David S

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

一项针对复发性神经母细胞瘤患者的高剂量DFMO、塞来昔布、环磷酰胺和拓扑替康联合治疗的I期研究:一项神经母细胞瘤治疗新方法试验

Hogarty, Michael D; Ziegler, David S; Franson, Andrea; Chi, Yueh-Yun; Tsao-Wei, Denice; Liu, Kangning; Vemu, Rohan; Gerner, Eugene W; Bruckheimer, Elizabeth; Shamirian, Anasheh; Hasenauer, Beth; Balis, Frank M; Groshen, Susan; Norris, Murray D; Haber, Michelle; Park, Julie R; Matthay, Katherine K; Marachelian, Araz